Time New York: Tue 26 Mar 02:30 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Gearing Up for Q4 Earnings Season: BBBY, STX & More

Zacks

Monday, January 7, 2019

A full week into 2019, we look toward new economic data after today’s opening bell to see if the markets can continue the terrific bullishness we saw on Friday, with the S&P 500 up nearly 3 1/2%, the Nasdaq 4%+ and the Dow up a whopping 747 points. This was the tonic markets had been hoping for following for selling during periods of uncertainty regarding trade static with China and a partially shut U.S. government.

ISM Services are expected at 10am ET this morning, and analysts hope for stronger figures than we saw last week from ISM Manufacturing, which came in beneath expectations and down to the lowest levels in over two years. Services, which makes up the lion’s share of domestic economic growth, brought a headline figure of 60.7% for November. We were also scheduled to see new Factory Orders today, but these results will be delayed due to the ongoing government shutdown, now in its third week.

Trade talks in Beijing with U.S. officials continue, although no concrete progress has been reported at this hour. What the U.S. is looking to obtain from its major trading partner is trade deficit reduction (by way of increasing U.S. exports to the company), structural reforms and compliance enforcement. Whether there is actual wiggle room for establishing any of this remains to be seen.

Q4 Earnings on the Horizon

We also find ourselves gearing up for a fresh round of earnings reports beginning tomorrow, with companies like Zacks Rank #2 (Buy)-rated Lindsay Corporation LNN, a crop irrigation specialist, and Zacks Rank #2-rated transportation supplier Greenbrier GBX reporting on Wednesday. The big banks aren’t reporting until next week, but we also look forward to results from Constellation Brands STX and Bed, Bath & Beyond BBBY this week.

The only current Zacks Rank #1 (Strong Buy) stock expected to release earnings this week is Saratoga Investment SAR, a middle-market debt financier. The small-cap investment firm, formerly known as GSC, has beaten earnings estimates in 4 out of the last 5 quarters, and its report is scheduled to come out Wednesday after the closing bell.

For a comprehensive look at Q4 earnings season before it begins, do not miss Zacks Director of Research Sheraz Mian’s latest Earnings Preview report: The Market’s Earnings Uncertainty

Mark Vickery
Senior Editor

Questions or comments about this article and/or its author? Click here>>

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.


So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.